You are here

Series B

Biotech startups face ‘Series A cliff’ as venture capital stays cautious

BioPharma Dive

Fri, 03/24/23 - 10:08 am

venture capital

Enterprise Therapeutics Raises $41 Million Series B Funding To Develop Muco-Regulatory Pipeline

CP Wire

Thu, 04/12/18 - 09:09 am

Enterprise Therapeutics

CRISPR Therapeutics adds $38M to series B pot, but lags behind Parker

Fierce Biotech

Fri, 06/24/16 - 09:32 am

CRISPR Therapeutics

Amgen spinoff Atara cranks its Series B up to $52M

Fierce Biotech

Fri, 01/10/14 - 06:58 pm

Merck backs Medivo in $15M in Series B round

Mass Device

Sat, 06/22/13 - 10:45 am

The Daily Start-Up: Xcovery Secures More Than $6M Series B to Advance Two Drug Candidates, Develop Others

WSJ Online

Tue, 09/18/12 - 11:52 am

Tioga nabs $10M VC deal amid PhIII for bowel disorder drug

Fierce Biotech

Fri, 04/13/12 - 10:51 am

venture capital

irritable bowel syndrome

TransEnterix closes $15M in 2nd tranche of Series B

Mon, 12/19/11 - 06:12 pm

Flexuspine adds $2.1M to Series B

Wed, 11/23/11 - 10:09 pm

NxThera raises $21.6 million in series B financing

Tue, 10/4/11 - 08:17 pm

Miracor raises $10M in Series B

Wed, 09/14/11 - 10:32 pm

Lantos appoints CEO, closes Series B round

Mon, 08/29/11 - 10:17 pm

Genomics co. OpGen lands $17.3M in Series B

Fierce Biotech

Mon, 09/27/10 - 12:14 pm

Dx company Veracyte lands $28M series B

Fri, 06/11/10 - 10:37 am

ClearCount raises $1.1 million in Series B round

Fri, 05/7/10 - 06:33 am